Abstract Details
|
Evan A. Jolliffe, MD
(Te Whata Ora Capital Coast & Hutt Valley)
PRESENTER |
No disclosure on file |
| Ian Rosemergy, MD | No disclosure on file |
| Ludwig Kappos, MD, FAAN (RC2NB, University Hospital Basel) | The institution of Dr. Kappos has received research support from Bayer. The institution of Dr. Kappos has received research support from Biogen. The institution of Dr. Kappos has received research support from Genentech. The institution of Dr. Kappos has received research support from Genzyme. The institution of Dr. Kappos has received research support from Janssen. The institution of Dr. Kappos has received research support from Merck Serono. The institution of Dr. Kappos has received research support from Minoryx. The institution of Dr. Kappos has received research support from Novartis. The institution of Dr. Kappos has received research support from Roche. The institution of Dr. Kappos has received research support from Sanofi. The institution of Dr. Kappos has received research support from Santhera. The institution of Dr. Kappos has received research support from Swiss MS Society, Swiss National Research Foundation, European Union, Roche Research Foundation, Innosuisse. The institution of Dr. Kappos has received research support from Shionogi. The institution of Dr. Kappos has received research support from Japan Tobacco. The institution of Dr. Kappos has received research support from Auriga Vision AG. The institution of Dr. Kappos has received research support from EMD Serono. The institution of Dr. Kappos has received research support from Glaxo Smith Kline. The institution of Dr. Kappos has received research support from Wellmera AG. The institution of Dr. Kappos has received research support from Eli Lilly (Suisse) SA. The institution of Dr. Kappos has received research support from Bristol Myers Squibb. The institution of Dr. Kappos has received research support from Celltrion Inc. Dr. Kappos has received intellectual property interests from a discovery or technology relating to health care. |
| Jeremiah W. Lanford, MD | No disclosure on file |
| David A. Abernethy, FRACP, MB, ChB | No disclosure on file |
| Anna Ranta, MD, PhD, FRACP, FAAN (University of Otago, Wellington) | The institution of Dr. Ranta has received research support from Health Research Council of New Zealand. The institution of Dr. Ranta has received research support from New Zealand Ministry of Health. The institution of Dr. Ranta has received research support from New Zealand Neurological Foundation. Dr. Ranta has a non-compensated relationship as a Treasurer with Stroke Society of Australasia that is relevant to AAN interests or activities. Dr. Ranta has a non-compensated relationship as a Board Member with World Stroke Organisation that is relevant to AAN interests or activities. Dr. Ranta has a non-compensated relationship as a President with Neurological Association of new Zealand that is relevant to AAN interests or activities. Dr. Ranta has a non-compensated relationship as a Editorial Board Member with 'Stroke' and 'Neurology' (Journals) that is relevant to AAN interests or activities. |